Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 8:59 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 150 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Bronchopulmonary Dysplasia Clear all

Conditions: Bronchopulmonary Dysplasia, Bronchopulmonary Dysplasia Associated Pulmonary Hypertension, Pulmonary Hypertension, Premature Birth, Chronic Lung Disease of Prematurity
Interventions: Enteral L-citrulline; Dietary Supplement
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: Up to 30 Weeks
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Prematurity, Bronchopulmonary Dysplasia, Intraventricular Hemorrhage, Periventricular Leukomalacia
Interventions: inhaled nitric oxide, oxygen; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 2 Hours to 72 Hours
Enrollment: 273 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Premature Infants, Bronchopulmonary Dysplasia, Intraventricular Hemorrhage, Neurodevelopmental Outcomes
Interventions: Sat75, Sat50; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 0 Minutes to 10 Minutes
Enrollment: 700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Necrotizing Enterocolitis, Bronchopulmonary Dysplasia, Growth Failure
Interventions: Not listed
Lead sponsor: University of California, Davis; Other
Eligibility: Up to 33 Weeks
Enrollment: 300 participants
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Bacteria Infection, Respiratory Tract Infections
Interventions: Azithromycin; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 1 Day to 3 Days
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Bronchopulmonary Dysplasia
Interventions: Montelukast; Drug
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 7 Days and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Preterm Infants, Respiratory Distress Syndrome (Neonatal), BPD - Bronchopulmonary Dysplasia
Interventions: Pressure Targeted High Flow, CPAP; Procedure
Lead sponsor: University of Texas at Austin; Other
Eligibility: 7 Days to 40 Weeks
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: San Diego, California • Austin, Texas

Conditions: Bronchopulmonary Dysplasia, Prematurity
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: Up to 7 Days
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 2
States / cities: Indianapolis, Indiana • Durham, North Carolina

Conditions: Bronchopulmonary Dysplasia
Interventions: transpyloric feeding, gastric feeding; Other
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 4 Weeks to 24 Weeks
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Bronchopulmonary Dysplasia, Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Extreme Prematurity, Ventilator Lung; Newborn, Ventilation Perfusion Mismatch
Interventions: Increase in the PEEP followed by decrease in the PEEP, Decrease in the PEEP followed by increase in the PEEP; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 7 Days to 30 Days
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Chronic Lung Disease of Prematurity, Respiratory Distress Syndrome in Premature Infant, Bronchopulmonary Dysplasia, Preterm Birth
Interventions: Pacifier Activated Lullaby ®; Device
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 1 Day to 33 Weeks
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Respiratory Distress Syndrome, Bronchopulmonary Dysplasia
Interventions: Not listed
Lead sponsor: National Center for Research Resources (NCRR); NIH
Eligibility: 0 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1996
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Severe Bronchopulmonary Dysplasia
Interventions: Albuterol Sulfate, Sterile Saline; Drug
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: Up to 1 Year
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Bronchopulmonary Dysplasia, Respiratory Distress Syndrome, Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature
Interventions: Minimal mechanical ventilation management, Routine mechanical ventilation management, Dexamethasone, Placebo; Procedure · Drug
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: 5 Minutes to 10 Days
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2002
U.S. locations: 13
States / cities: Birmingham, Alabama • Palo Alto, California • New Haven, Connecticut + 10 more

Conditions: Prematurity; Extreme, Feeding Patterns, Ventilator Lung; Newborn
Interventions: Continuous Feeds, Intermittent Bolus Feeds; Other
Lead sponsor: Rajeev Kumar; Government
Eligibility: Not listed
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Bronchopulmonary Dysplasia
Interventions: GSNO; Drug
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 29 Days to 365 Days
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Retinopathy of Prematurity, Bronchopulmonary Dysplasia (BPD)
Interventions: Inositol lower volume, Inositol higher volume, Placebo lower volume, Placebo higher volume; Drug
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: 3 Days to 6 Days
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 11
States / cities: New Haven, Connecticut • Indianapolis, Indiana • Detroit, Michigan + 7 more

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Bronchopulmonary Dysplasia
Interventions: Exosurf, Survanta; Drug
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: Up to 6 Hours
Enrollment: 617 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1991 – 1992
U.S. locations: 13
States / cities: Palo Alto, California • New Haven, Connecticut • Washington D.C., District of Columbia + 10 more

Conditions: Infant, Premature, Bronchopulmonary Dysplasia, Asthma
Interventions: Not listed
Lead sponsor: Indiana University; Other
Eligibility: 2 Months to 2 Years
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Pulmonary Hypertension, Bronchopulmonary Dysplasia
Interventions: inhaled nitric oxide, Placebo; Drug
Lead sponsor: AdventHealth; Other
Eligibility: 23 Weeks to 29 Weeks
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Bronchopulmonary Dysplasia (BPD)
Interventions: Metformin (open-label); Drug
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 7 Days to 6 Months
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Bronchopulmonary Dysplasia, Apnea of Prematurity
Interventions: Caffeine, Placebo (dextrose); Drug
Lead sponsor: Wayne State University; Other
Eligibility: Up to 4 Weeks
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Bronchopulmonary Dysplasia (BPD)
Interventions: CPAP, Nasal Cannula; Device
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: Up to 31 Weeks
Enrollment: 860 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 15
States / cities: Birmingham, Alabama • Palo Alto, California • San Diego, California + 12 more

Conditions: Infant, Newborn, Diseases, Other Preterm Infants, Infant, Small for Gestational Age, Premature Birth, Bronchopulmonary Dysplasia, Retinopathy of Prematurity
Interventions: Surfactant, Continuous Positive Airway Pressure (CPAP), Supplemental oxygen with target saturation of 85 to 89%, Supplemental oxygen with target saturation of 91 to 95%; Drug · Device
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: 24 Weeks to 27 Weeks
Enrollment: 1,316 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2016
U.S. locations: 22
States / cities: Birmingham, Alabama • Palo Alto, California • San Diego, California + 18 more

Search by objective public record fields.

Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and Dosing

Inhaled Nitric Oxide and Neuroprotection in Premature Infants

Optimization of Saturation Targets And Resuscitation Trial (OptiSTART)

A Cohort Study of the Intestinal Microbiota of Premature Infants

Early Versus Expectant Treatment of Ureaplasma Infection in Very Low Birth Weight Neonates

Montelukast in Very Low Birthweight Infants

Pressure Targeting During High Flow Therapy in Premature Infants

Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia

Transpyloric Feeding in Severe Bronchopulmonary Dysplasia

Ventilator Pressure and Optimization of Compliance and Hemodynamics

PAL to Improve Oral Feeding for Infants With Chronic Lung Disease

Study of the Pathobiology of Bronchopulmonary Dysplasia in Newborns

Aerosolized Albuterol Use in Severe BPD

Minimal Breathing Support and Early Steroids to Prevent Chronic Lung Disease in Extremely Premature Infants (SAVE)

To Determine the Best Feeding Practice in Preterm Infants on Non-invasive Ventilation.

Inhaled Treatment for Bronchopulmonary Dysplasia

Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants

Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome

Assessment of the Pulmonary Diffusion Capacity in Healthy Infants and Infants With Chronic Lung Disease

Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia

Metformin for Premature Infants With Bronchopulmonary Dysplasia

Early Versus Late Caffeine for ELBW Newborns

Continued Pressure for Alveolar Protection (CPAP Trial)

Surfactant Positive Airway Pressure and Pulse Oximetry Trial